Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 2/20 | 0.72 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9188366 | 1.00 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24522855 | 1.00 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL6599915 | 0.94 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL6592785 | 0.90 | KCNA3 (0.69) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24522923 | 0.86 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24523105 | 0.86 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24522756 | 0.86 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL14802497 | 0.86 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24237031 | 0.86 | KCNA3 (0.97) | KCNA3CA12CA1CA9MAOB | |
| SCHEMBL24237029 | 0.86 | KCNA3 (0.72) | KCNA3CA12CA1CA9MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022128832-A1 | OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| EP-4015512-A1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2022-06-22 | — | — | EP | disclosed |